PMID-sentid	Pub_year	Sent_text		comp_official_name	comp_offsetprotein_name	organism	prot_offset
30247247-1	2018	OBJECTIVES: Cisplatin and mitomycin C exert high activity towards BRCA1-deficient cells.	Cisplatin	12-21	BRCA1 DNA repair associated	Homo sapiens	66-71	
30247247-7	2018	CONCLUSIONS: The combination of cisplatin plus mitomycin C showed promising results in BRCA1-driven OC and therefore deserves further clinical evaluation.	Cisplatin	32-41	BRCA1 DNA repair associated	Homo sapiens	87-92